Charcot-Marie-Tooth disease axonal type 2P is a rare inherited nerve disease that mainly damages the long nerves to the feet, legs, hands, and sometimes arms. It is caused by changes in a gene called LRSAM1, which affects how nerve cells keep their structure and clear damaged proteins. Because the long nerves are affected first, people may notice weakness in the feet and ankles, tripping, difficulty running, and loss of feeling in the legs and later the hands.Genetic Rare Diseases Center+2MalaCards+2
Charcot-Marie-Tooth disease axonal type 2P (often called CMT2P) is a rare, inherited nerve disease. It mainly affects the long nerves that go to the feet, legs, hands, and arms. These nerves are called peripheral nerves. In CMT2P, the problem is in the axon. The axon is the long “wire” part of a nerve cell that carries electrical signals. Because the axons are damaged, messages from the brain to the muscles and from the skin to the brain become weak or lost. This causes weakness, wasting of muscles, and loss of feeling, especially in the feet and legs. CMT2P is caused by changes (mutations) in a gene called LRSAM1. Monarch Initiative+3Genetic Rare Diseases Center+3MalaCards+3
CMT2P is an axonal neuropathy, which means the main problem is in the “wire” part of the nerve rather than the myelin coating. Over time, muscles that depend on these nerves become thin and weak, leading to high arches, hammer toes, foot drop, and hand weakness. Some people also have cramps and twitching. The condition usually progresses slowly over many years, and life expectancy is usually normal, but disability can build up if it is not managed well.Genetic Rare Diseases Center+2PMC+2
At present, there is no cure and no drug that specifically stops or reverses CMT2P, so treatment focuses on protecting nerves as much as possible, keeping muscles strong and flexible, preventing deformities, and treating pain and fatigue. Management is very similar to other types of Charcot-Marie-Tooth disease and relies heavily on physiotherapy, orthotics, lifestyle care and pain medicines. Future research is looking at gene therapy and regenerative approaches, but these are still experimental.PubMed+3Mayo Clinic+3Physiopedia+3
In most people, CMT2P starts in early or mid-adult life and gets worse slowly over many years. It usually affects the lower limbs first. Later, the hands and arms can also be affected. The condition can be inherited in an autosomal dominant way (one changed copy of the gene is enough to cause disease) or in an autosomal recessive way (both copies of the gene are changed). PubMed+3Genetic Rare Diseases Center+3ScienceDirect+3
Other names
Doctors and researchers may use several different names for Charcot-Marie-Tooth disease axonal type 2P. These names all refer to the same or very closely related conditions:
Charcot-Marie-Tooth disease type 2P
CMT2P
Charcot-Marie-Tooth disease axonal type 2P
LRSAM1-related Charcot-Marie-Tooth disease
LRSAM1-related axonal hereditary motor and sensory neuropathy
Some databases also list very close synonyms such as “Charcot-Marie-Tooth disease type 2P associated with LRSAM1 mutation.” National Organization for Rare Disorders+1
Types
Doctors do not have strict official “sub-types” inside CMT2P in the way they do for all CMT (CMT1, CMT2, etc.). But they often describe clinical patterns and inheritance patterns that behave like types. These “types” help doctors understand the course of the disease and explain it to patients.
1. Autosomal dominant CMT2P
In this pattern, a person needs only one changed copy of the LRSAM1 gene. The affected parent can pass the changed gene to a child with a 50% chance in each pregnancy. This form often has a milder course and very slow progression. Symptoms may start from the second to the fifth decade of life. ScienceDirect+2Springer Link+2
2. Autosomal recessive CMT2P
In the recessive pattern, a person needs two changed copies of the gene, one from each parent. Parents are usually healthy carriers. This form can sometimes start earlier and may be more severe, but it is rarer.
3. Early-onset CMT2P
Some families have symptoms starting in adolescence or even earlier adulthood. People may notice tripping, difficulty running in school, or early foot deformities. Research has described families with early-onset autosomal dominant CMT2P due to specific LRSAM1 variants. ScienceDirect+1
4. Late-onset CMT2P
In many people, weakness and numbness do not begin until mid-life or later. They may first notice problems with balance, falls, or foot pain in their 30s, 40s, or 50s. The disease is still slow, but people may already have other health problems that interact with the neuropathy.
5. Mild CMT2P
Some individuals have a very mild form. They may have only subtle weakness in the feet, slight loss of vibration sense, or small balance problems. They can stay independent in daily activities for many years and sometimes for life. MalaCards+1
6. Moderate to more severe CMT2P
Others have more obvious weakness, wasting of leg muscles, and foot deformities. They may need ankle-foot orthoses or walking aids. Hands can become weak later, making it hard to button clothes or write. Autonomic symptoms such as urinary urgency or erectile problems can appear in some people. MalaCards+1
Causes
Remember: the main true cause of CMT2P is a genetic change in the LRSAM1 gene. Many of the “causes” described below are more like mechanisms or factors that make the disease worse, not separate diseases.
1. Mutation in the LRSAM1 gene
This is the central cause. LRSAM1 is a gene that gives instructions to make a protein called an E3 ubiquitin ligase. This protein helps mark other proteins for recycling or breakdown. When LRSAM1 is changed, this process does not work correctly, and nerve cells are harmed over time. ScienceDirect+2Springer Link+2
2. Abnormal E3 ubiquitin ligase function
The E3 ligase encoded by LRSAM1 normally tags damaged or unneeded proteins inside nerve cells. With a faulty E3 ligase, unwanted proteins are not removed properly. They can build up and disturb the normal work of the cell. This chronic stress can slowly damage the long axons of peripheral nerves.
3. Problems with protein sorting and recycling inside nerve cells
LRSAM1 is involved in endosomal pathways and protein sorting. When this pathway is disturbed, proteins and membrane parts may not be sent to the right place at the right time. Over many years, this mis-sorting damages the long, thin axons that must stay healthy for normal sensation and movement. Springer Link+1
4. Axonal degeneration of long peripheral nerves
The longest nerves, such as those going to the feet, are most vulnerable. Because the main defect is in the axon, not in the myelin, the nerve conduction velocity can be near normal, but the strength of signals is reduced. This axonal degeneration is a direct effect of the gene defect plus stress over time. Charcot-Marie-Tooth Association+2CMT Research Foundation+2
5. Autosomal dominant inheritance
When CMT2P is autosomal dominant, one mutated gene copy is enough to disturb nerve function. Every generation may have affected people. This inherited pattern explains why disease appears repeatedly in some families.
6. Autosomal recessive inheritance
In some families, disease appears only when a child receives two mutated copies. Parents are carriers without symptoms. This pattern explains why CMT2P sometimes appears in siblings but not in parents.
7. De novo (new) LRSAM1 mutation
In rare cases, the mutation may appear for the first time in a person, without a family history. This can happen during the formation of egg or sperm, or early after conception. The person can then pass the new mutation to future children.
8. Different types of mutation (missense, nonsense, frameshift, splice-site)
The LRSAM1 gene can be altered in many ways: a single amino acid change (missense), a premature stop signal (nonsense), a shift in the reading frame (frameshift), or problems in cutting and joining RNA (splice-site). Each type may change the protein in a slightly different way but still leads to axonal damage. ScienceDirect+1
9. Additional genetic modifiers
Other genes that affect nerve health, mitochondria, or myelin can modify how severe CMT2P becomes. For example, a person with both an LRSAM1 mutation and another mild neuropathy gene variation might have worse symptoms than someone with only one change.
10. Age-related nerve wear and tear
All people lose some nerve function with age. In CMT2P, this natural aging process adds on top of an already fragile axon, so symptoms often become more noticeable later in life.
11. Co-existing diabetes
Diabetes can cause its own type of nerve damage (diabetic neuropathy). If a person with CMT2P also has diabetes, the two forms of nerve injury can “stack up,” leading to faster or more severe loss of feeling and strength.
12. Vitamin deficiencies (for example, vitamin B12 or B1 lack)
Low levels of certain vitamins, especially B12 and B1, harm nerves. In someone with CMT2P, this can worsen symptoms, although it does not create the LRSAM1 mutation itself. Correcting these deficiencies can sometimes improve overall nerve function a little.
13. Chronic kidney or liver disease with toxin build-up
If kidneys or liver do not clean the blood well, toxins can stay in the body and injure nerves. This can make the neuropathy in CMT2P more severe.
14. Use of nerve-toxic drugs (for example, some chemotherapy drugs)
Certain chemotherapy medicines and other drugs are known to injure peripheral nerves. In a person with CMT2P, these drugs may cause extra damage. That is why doctors try to choose less neurotoxic treatments when possible and monitor nerve health closely.
15. Heavy alcohol use
Long-term high alcohol intake can cause alcoholic neuropathy. When added to CMT2P, it can result in earlier and more serious weakness and numbness. Stopping alcohol can help prevent further damage.
16. Smoking and poor blood flow to nerves
Smoking damages blood vessels, including the tiny vessels that feed nerves. Poor blood flow means less oxygen and nutrients. This worsens axonal injury in CMT2P and may speed up muscle wasting.
17. Long-term mechanical pressure on nerves
Because CMT2P often causes high-arched feet and other deformities, certain nerves can be compressed by bones or tight shoes. This pressure adds new injury to already fragile nerves and may lead to focal (local) nerve problems, such as peroneal nerve palsy at the fibular head.
18. Obesity and metabolic syndrome
Excess weight and metabolic syndrome can reduce physical activity and worsen blood vessel health. Less movement and poorer circulation make neuropathic symptoms more disabling, even though they do not create the original gene mutation.
19. Infections that affect the peripheral nerves
Some infections can injure nerves or trigger strong immune reactions. In someone with CMT2P, such episodes can temporarily or permanently worsen symptoms like weakness or numbness.
20. Physical inactivity and muscle deconditioning
When muscles are not used, they become weaker and smaller. In CMT2P, where nerves already struggle to activate muscles, inactivity leads to faster disability. Regular, safe exercise tailored by a physiotherapist can help slow this deconditioning.
Symptoms
Symptoms vary from person to person, even inside the same family. They usually begin in the feet and legs and progress slowly. CMT Research Foundation+3Genetic Rare Diseases Center+3MalaCards+3
1. Numbness in the feet and lower legs
People often first notice that their feet feel “dead,” “thick,” or “asleep.” They may not feel small stones in their shoes or may not feel water temperature well. This happens because the sensory axons that carry touch and pressure signals are damaged.
2. Numbness in the fingertips
Later in the disease, the numbness can reach the hands and fingertips. Fine tasks like picking up coins, typing, or closing small buttons may feel strange or clumsy because sensation is reduced.
3. Loss of vibration sense
Vibration sense (for example, feeling a tuning fork on the ankle or toe) is often the most affected. Doctors can test this easily. When vibration is lost, people may not sense how their feet touch the ground, which affects balance. Genetic Rare Diseases Center+1
4. Poor balance, especially in the dark or on uneven ground
Because people cannot clearly feel where their feet are, they rely more on sight for balance. In the dark, or when closing the eyes, they may sway or fall more easily. This is partly due to loss of proprioception (the sense of where body parts are in space).
5. Tingling, pins-and-needles, or burning feelings
Some people feel abnormal sensations, such as tingling, crawling feelings, or burning pain in the feet and legs. These are called “positive sensory symptoms” and come from irritated but damaged nerve fibers.
6. Muscle weakness in the feet and ankles
Weakness usually starts in the muscles that lift the front of the foot and move the toes. People may have trouble lifting the foot when walking. They may notice tripping over small obstacles or catching their toes on carpets.
7. Foot drop and slapping gait
Because the front of the foot does not lift well, people can develop “foot drop.” They may raise their knees higher when walking and the foot may slap the floor. This gait pattern is typical in many forms of CMT, including CMT2P. Charcot-Marie-Tooth Association+2CMT Research Foundation+2
8. High-arched feet (pes cavus) and other foot deformities
Many people with CMT2P develop high arches, clawed toes, or other deformities as certain muscles become weaker than others. Over time, tight tendons and imbalanced pull of muscles shape the bones of the foot. This can cause pain, calluses, and difficulty finding comfortable shoes. MalaCards+1
9. Wasting (thinning) of leg muscles
As nerves fail to activate muscles, the calf muscles and small muscles of the feet shrink. Legs may look thin below the knees, while thighs may look relatively normal. This is sometimes described as “inverted champagne bottle” appearance in CMT.
10. Weakness and wasting in the hands
Later in the disease, the small muscles of the hands can also become weak and thin. This makes it harder to grip small objects, write for long periods, or perform fine tasks like sewing.
11. Muscle cramps
Children and younger adults with CMT2P may notice painful cramps in the calves or feet, especially at night or after exercise. These cramps come from unstable, over-excited nerve fibers in partly damaged axons. Genetic Rare Diseases Center+1
12. Fasciculations (muscle twitches)
Small, fine twitches under the skin can occur in the legs or arms. These fasciculations are brief, involuntary discharges in groups of muscle fibers, often seen when motor axons are injured.
13. Reduced or absent tendon reflexes
When doctors tap the knee or ankle with a reflex hammer, the response may be very weak or missing. This happens because the reflex arc needs healthy sensory and motor axons. In CMT2P, those axons are impaired.
14. Fatigue and difficulty walking long distances
Because the muscles are weak and balance is poor, walking uses more energy. People can feel tired after short walks, may avoid long distances, and may need frequent rests.
15. Autonomic symptoms (for some people)
A few people with CMT2P may have autonomic problems such as urinary urgency, erectile dysfunction, or issues with sweating. These symptoms arise if autonomic nerve fibers are also affected. MalaCards+1
If you notice symptoms like these, it is important to see a neurologist. They can check whether CMT or another cause is present.
Diagnostic tests
There is no single simple test in daily life that proves CMT2P, but doctors can build the diagnosis step by step. They start with a careful history and physical examination. Then they use manual bedside tests, laboratory and pathological tests, electrodiagnostic tests, and imaging tests. The most specific test for CMT2P is genetic testing, which looks for mutations in the LRSAM1 gene. PubMed+3Genetic Rare Diseases Center+3ScienceDirect+3
Physical exam tests (bedside observation by the doctor)
1. General neurological examination
The doctor looks at the whole nervous system. They test strength, reflexes, feeling, coordination, and cranial nerves. In CMT2P, they often see distal muscle weakness and wasting, reduced reflexes, and sensory loss in a “stocking-and-glove” pattern. This broad exam helps rule out brain or spinal cord diseases and keeps the focus on peripheral neuropathy.
2. Muscle strength grading in limbs
Using a simple scale from 0 to 5, the doctor checks how strong each muscle group is. They press against your foot, ankle, knee, wrist, and fingers and ask you to resist. In CMT2P, distal muscles (far from the trunk) like ankle dorsiflexors and toe extensors are usually weaker than proximal muscles. This pattern fits an axonal length-dependent neuropathy.
3. Sensory examination for touch, pain, and temperature
The doctor uses light touch (with cotton or a finger), a pin or toothpick for sharpness, and sometimes cold or warm objects to see how well you feel. In CMT2P, sensation is often reduced more in the feet and legs than in the hands and arms, and vibration sense is especially impaired. Genetic Rare Diseases Center+1
4. Deep tendon reflex testing (for example, ankle and knee jerks)
The doctor taps tendons like the Achilles tendon at the ankle or the patellar tendon at the knee with a reflex hammer. In CMT2P, these reflexes are frequently reduced or absent, especially at the ankles, because the reflex arc nerves are damaged. This finding supports the diagnosis of a peripheral neuropathy.
5. Inspection of feet and hands for deformities
The doctor looks at the shape of the feet and hands. High arches (pes cavus), hammertoes, and small intrinsic hand muscles wasting are common signs in CMT. These visible changes provide clues that the neuropathy has been present for many years, supporting a chronic inherited process like CMT2P. MalaCards+2Orpha.net+2
Manual bedside tests (simple functional tests)
6. Gait assessment and heel-toe walking
The doctor asks you to walk normally, on your heels, and on your toes. In CMT2P, walking on heels may be very hard because the muscles that lift the toes are weak. The doctor also watches for high-stepping gait and foot slap. This manual test shows how neuropathy affects real-life walking.
7. Romberg test (balance with eyes closed)
You are asked to stand with feet together and eyes open, then closed. If you sway much more or fall when the eyes are closed, it suggests poor proprioception. This often occurs in CMT2P because the large sensory fibers that carry joint and position sense are affected.
8. Manual muscle testing of ankle and toe movements
The doctor specifically checks the muscles that lift and turn the foot, such as tibialis anterior and peroneal muscles. They may ask you to push against their hand in different directions. Distal weakness in these muscles is a hallmark of CMT2P and helps distinguish it from some other conditions.
9. Tuning fork vibration test
A vibrating tuning fork (often 128 Hz) is placed on your big toe, ankle, knee, and fingers. You say when you can feel the vibration and when it stops. In CMT2P, vibration sense is often lost early at the toes and ankles. This simple manual test is very sensitive for large-fiber neuropathy. Genetic Rare Diseases Center+2MalaCards+2
10. Timed walking or sit-to-stand tests
The doctor may time how long it takes you to walk a certain distance or to stand up from a chair several times. These simple tests show how the neuropathy affects everyday function and can be repeated over time to track progression or response to supportive therapies.
Laboratory and pathological tests
11. Basic blood tests to rule out other neuropathy causes
Although CMT2P is genetic, doctors must exclude other treatable causes of neuropathy. They may test blood sugar, kidney and liver function, vitamin B12 and B1 levels, thyroid hormones, and sometimes autoimmune markers. If these are abnormal, treatment may improve nerve health even if the CMT2P gene change is still present.
12. Serum protein electrophoresis and immunofixation
These blood tests look for abnormal proteins produced in some blood cancers or immune conditions that can cause neuropathy. A normal result supports the idea that the neuropathy is inherited (like CMT2P) rather than acquired from a monoclonal gammopathy or related disorder.
13. Genetic testing panel for CMT genes
This is one of the most important tests. A blood sample is taken, and many CMT-related genes, including LRSAM1, are analyzed. Finding a disease-causing mutation in LRSAM1 confirms the diagnosis of CMT2P. Modern gene panels or whole-exome sequencing are strongly recommended for people with suspected inherited neuropathy. ScienceDirect+2Springer Link+2
14. Targeted LRSAM1 gene sequencing
If a family is already known to have a specific LRSAM1 mutation, targeted testing can be done in relatives. This test checks only that gene and position. It is faster and cheaper than broad panels and is used for family screening and genetic counseling.
15. Nerve biopsy (rarely needed today)
In the past, a small piece of nerve (often the sural nerve near the ankle) was sometimes taken for microscopic study. In axonal CMT like CMT2P, biopsy shows axonal loss and regeneration clusters, but it is not specific. Because genetic testing is now widely available, nerve biopsy is usually reserved for unclear cases or research, not for routine diagnosis. Wikipedia
Electrodiagnostic tests
16. Nerve conduction studies (NCS)
Electrodes are placed on the skin, and small electrical pulses are sent along the nerves. The test measures how fast and how strong signals travel. In CMT2P, conduction velocity is often normal or only slightly reduced, but amplitudes (signal size) are low, which matches an axonal neuropathy. This helps distinguish CMT2P from demyelinating forms like CMT1. Charcot-Marie-Tooth Association+2CMT Research Foundation+2
17. Electromyography (EMG)
A fine needle electrode is inserted gently into various muscles. The EMG records electrical activity at rest and with contraction. In CMT2P, EMG shows signs of chronic denervation and reinnervation (for example, large motor unit potentials). It also helps exclude other disorders like motor neuron disease, which have different EMG patterns.
18. F-wave and late response studies
NCS can also look at F-waves, which are late responses traveling up and down the motor nerves. In CMT2P, these may show changes consistent with axonal loss but usually without the marked slowing seen in demyelinating neuropathies. These detailed measurements give extra information about motor nerve function.
Imaging tests
19. X-rays or CT scans of feet and ankles
Imaging of the feet can show high arches, hammertoes, or other structural changes caused by long-term muscle imbalance. These images help orthopedic surgeons and physiatrists plan braces, footwear, or surgery if needed. They do not diagnose CMT2P alone but show its impact on bones and joints.
20. MRI or ultrasound of nerves and spine (when needed)
Sometimes doctors use MRI or ultrasound to look at the peripheral nerves or spine. In CMT2P, nerves may be slightly thickened but usually not as much as in some demyelinating forms. MRI of the spine can help rule out other causes of weakness and sensory loss, such as spinal cord compression. Ultrasound can show nerve size and structure in a non-invasive way. These imaging tests support the diagnosis and exclude other conditions. Charcot-Marie-Tooth Association+2CMT Research Foundation+2
Non-pharmacological treatments ( therapies and others)
1. Individualized physiotherapy program
Physiotherapy is one of the most important non-drug treatments in CMT2P. A therapist designs safe, low-impact exercises to keep muscles strong, joints flexible, and movement smooth. Typical programs use stretching, gentle strengthening, balance work, and sometimes water exercises. The main purpose is to slow muscle shortening, reduce contractures, and help you walk more safely. Physiotherapy works by repeatedly training muscles and nerves, improving motor patterns and reducing the strain on already weak nerves and joints.nhs.uk+2PMC+2
2. Stretching to prevent contractures
Daily stretching of ankles, calves, hamstrings, and fingers helps stop joints from becoming stiff and bent over time. In CMT2P the muscles around the ankle and foot are weak, so stronger muscles can pull joints into fixed positions. The purpose of stretching is to keep normal joint range, delay deformities such as equinus (toe-walking) and clawed toes, and reduce pain. Stretching works by gently lengthening muscles and tendons and reminding the nervous system that the joint can still move.nhs.uk+1
3. Strengthening of preserved muscles
Therapists often focus on muscles that are less affected, such as hips, thighs, and core muscles. The purpose is to let strong muscles support weak areas and keep overall mobility. Low-resistance, high-repetition exercises are usually safer than heavy weights. This kind of training works by improving muscle fiber endurance and coordination without overworking the fragile distal nerves that are already damaged in CMT2P.PMC+1
4. Balance and gait training
Many people with CMT2P have poor sensation in their feet and ankles, so the brain gets less information about where the body is in space. The purpose of balance training is to reduce falls and teach safer walking patterns, sometimes with visual cues or walking on different surfaces under supervision. Mechanistically, repeated practice improves “proprioceptive” feedback from skin, muscles, and joints, and helps the brain use vision and inner-ear balance more efficiently.Mayo Clinic+2ScienceDirect+2
5. Ankle-foot orthoses (AFOs) and bracing
Lightweight braces or splints around the ankle and foot help correct foot drop and ankle instability, making walking safer and less tiring. The purpose is to support alignment, prevent tripping, and allow a more normal heel-to-toe step. Braces work mechanically by holding the foot at a safer angle, stabilizing weak joints, and spreading pressure more evenly on the sole, which also protects skin with reduced sensation.Mayo Clinic+2Charcot-Marie-Tooth Association+2
6. Custom shoes and insoles
Special footwear with wide toe boxes, cushioned soles, and custom insoles can protect deformed feet and reduce pressure points. The purpose is to improve comfort, prevent skin breakdown, and accommodate high arches or hammer toes. These devices work by redistributing weight, absorbing shock, and matching the shape of the foot, which is especially important when feeling in the feet is poor.Mayo Clinic+2nhs.uk+2
7. Occupational therapy for hand and daily tasks
Occupational therapists help people with CMT2P adapt to weakness in hands and arms. They teach joint-protection techniques, recommend adapted pens, cutlery, and computer devices, and show how to save energy during daily tasks. The purpose is to keep independence at school, work, and home. These strategies work by simplifying tasks, reducing strain on small hand muscles, and using larger, stronger muscles when possible.PMC+1
8. Podiatry and regular foot care
Because feeling in the feet may be reduced, small wounds can go unnoticed and become infected. Regular visits to a podiatrist for nail care, callus removal, and skin checks are important. The purpose is early detection of problems and prevention of ulcers. This approach works by combining visual inspection, gentle debridement, and education so the patient and family also learn to check the feet daily.nhs.uk+1
9. Pain self-management and relaxation techniques
Chronic neuropathic pain can be exhausting. Non-drug methods such as mindfulness, breathing exercises, relaxation training, gentle yoga, and heat or cold packs can help. The purpose is to lower pain intensity and reduce stress response. These approaches work by calming the nervous system, reducing muscle tension around weak joints, and changing how the brain processes pain signals, which can complement medical pain treatments.PMC+1
10. Fatigue management and energy conservation
Fatigue is common because weak muscles work harder for basic tasks. Therapists teach pacing, planned rest breaks, using chairs for tasks, and spreading heavy activities through the week. The purpose is to keep participation in school, work, and family life without worsening symptoms. This works by balancing activity and rest so nerves and muscles are not pushed beyond their capacity, which can otherwise increase pain and fall risk.PMC+1
11. Assistive devices (canes, walkers, wheelchairs when needed)
Some people benefit from a cane or walker, especially outdoors or on uneven ground. In more advanced stages, a lightweight wheelchair may help for longer distances. The purpose is to increase safety, independence, and participation, not to “give up walking.” These devices work mechanically by enlarging the base of support, off-loading weak muscles, and reducing the risk and fear of falling.Mayo Clinic+1
12. Home and school safety modifications
Simple changes like removing loose rugs, adding grab bars in the bathroom, using non-slip mats, and improving lighting can lower fall risk. In school or work, ramps, elevators, and different seating may be needed. The purpose is to create an environment that fits the person’s abilities. This works by reducing environmental hazards, which is particularly important when balance and sensation are impaired.Mayo Clinic+1
13. Orthopedic monitoring for deformities and scoliosis
Regular review by an orthopedic specialist helps detect worsening foot deformity, ankle instability, or spinal curvature. The purpose is to intervene early with braces or surgery before permanent damage occurs. The mechanism here is preventive: repeated examination and X-rays find structural problems while they are still easier to correct.nhs.uk+1
14. Respiratory and sleep evaluation in more advanced cases
Most people with CMT2P do not have serious breathing problems, but if trunk muscles are affected or there are nighttime symptoms such as snoring or poor sleep, respiratory assessment may be needed. The purpose is to detect rare but important complications like sleep apnea or weak breathing muscles. Tests like spirometry and sleep studies work by measuring how well the lungs and respiratory muscles are functioning during rest and sleep.Mayo Clinic+1
15. Speech and swallowing therapy (if bulbar involvement)
If speech or swallowing become affected, a speech-language therapist can help with exercises and safety strategies. The purpose is to prevent choking, weight loss, and communication problems. Therapy works by training the muscles involved in speech and swallowing and teaching safer ways to eat and drink.PMC+1
16. Psychological support and counseling
Living with a chronic genetic nerve disease can cause sadness, anxiety, or frustration. Talking with a psychologist, counselor, or support group can help. The purpose is to support mental health, coping skills, and self-esteem. These approaches work by giving a safe space to express emotions, learn stress-management tools, and connect with others who understand CMT.PMC+1
17. Peer support and patient organizations
CMT-specific organizations and online communities provide information, practical tips, and emotional support. The purpose is to reduce isolation and give access to current research news and resources. These groups work by connecting patients, families, and experts, sometimes also helping people join clinical trials.Charcot-Marie-Tooth Association+2CMT Research Foundation+2
18. Nutrition counseling and weight management
Extra body weight puts more stress on already weak feet and ankles and can worsen pain. A dietitian can help build a balanced diet that supports nerve health and keeps a healthy weight. The purpose is to reduce mechanical stress on joints and lower the risk of diabetes and other conditions that can worsen neuropathy. This works by improving overall metabolism, which indirectly protects nerves and muscles.nhs.uk+1
19. Avoidance of neurotoxic substances
Some medicines (like certain chemotherapy drugs), heavy alcohol use, and uncontrolled diabetes can further damage peripheral nerves. The purpose of avoiding or carefully managing these triggers is to prevent “extra” nerve injury on top of CMT2P. This works by reducing cumulative nerve damage, giving remaining axons a better chance to keep functioning.nhs.uk+1
20. Genetic counseling and family planning support
Because CMT2P is inherited, genetic counseling helps families understand inheritance patterns, testing options, and risks for future children. The purpose is informed decision-making and emotional support. Counseling works by explaining in simple language how LRSAM1 mutations are passed on, what tests exist, and what research is happening in gene therapy and other future options.Genetic Rare Diseases Center+2ScienceDirect+2
Drug treatments
Important: No medicine is currently approved to cure CMT2P. Most drugs below are used to treat neuropathic pain, cramps, mood, or related problems. Many are approved for other causes of neuropathy (like diabetes) and may be used off-label in CMT under a neurologist’s supervision.
I will mention only general adult starting doses from FDA labels or major reviews as examples. Exact dose and timing must always be decided by your doctor.
1. Pregabalin (Lyrica)
Pregabalin is a nerve-pain medicine used for neuropathic pain in conditions like diabetic nerve damage and post-herpetic neuralgia.FDA Access Data+1 It is a gabapentinoid that calms overactive nerve cells by binding to calcium channels in the spinal cord and brain. A common adult starting dose for neuropathic pain is 75 mg twice daily (150 mg/day), increased if needed and tolerated.FDA Access Data+1 The purpose in CMT2P is to reduce burning, shooting, or tingling pain in feet and hands. Side effects can include dizziness, sleepiness, weight gain, and swelling, so medical supervision is essential.FDA Access Data+1
2. Gabapentin (Neurontin and related products)
Gabapentin is another gabapentinoid widely used for neuropathic pain and as an anti-seizure medicine. FDA labels show it is approved for post-herpetic neuralgia and as add-on therapy in partial seizures, but it is also used for many neuropathic pain conditions.FDA Access Data+2FDA Access Data+2 Typical neuropathic pain doses range from about 1800–3600 mg/day, split into several doses, but titration is slow and individualized.PubMed+1 It works by modulating calcium channels and reducing abnormal nerve firing. Common side effects are dizziness, sleepiness, and balance problems.FDA Access Data+1
3. Duloxetine (Cymbalta)
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI) approved for diabetic peripheral neuropathic pain, fibromyalgia, depression, and anxiety.FDA Access Data+3FDA Access Data+3FDA Access Data+3 For neuropathic pain, FDA labels often use 60 mg once daily after a lower starting dose. It works in the brain and spinal cord by increasing serotonin and norepinephrine, chemicals that dampen pain signals. In CMT2P, it may reduce burning and shooting pain and improve mood. Side effects can include nausea, dry mouth, sleepiness, sweating, and sometimes changes in blood pressure or blood sugar.FDA Access Data+1
4. Other SNRIs (for example, venlafaxine)
Venlafaxine is another SNRI that is sometimes used off-label for neuropathic pain when duloxetine is not suitable. Clinical studies suggest SNRIs can decrease pain by acting on descending inhibitory pain pathways. The purpose in CMT2P is similar: reduce nerve pain and treat co-existing depression or anxiety. Side effects may include nausea, raised blood pressure, and sleep changes, so doctors monitor carefully.NCBI+1
5. Tricyclic antidepressants (TCAs: amitriptyline, nortriptyline)
TCAs are older antidepressants often used at low doses at night for neuropathic pain. They block reuptake of serotonin and norepinephrine and also block certain sodium channels, which decreases pain signaling. In CMT2P, low-dose amitriptyline or nortriptyline may help night pain and sleep. The purpose is symptom relief, not disease change. Side effects can include dry mouth, constipation, blurred vision, and heart rhythm changes, so ECG monitoring is sometimes needed.NCBI+1
6. Topical lidocaine (patch or gel)
Lidocaine patches are FDA-approved for post-herpetic neuralgia and sometimes used off-label for localized neuropathic pain in the feet. They work by blocking sodium channels in the skin nerves so they cannot fire easily. The purpose in CMT2P is to calm very painful, small areas without system-wide side effects. Typical regimens involve applying a patch for up to 12 hours in 24, but exact instructions depend on the product label. Side effects are usually local skin irritation.nhs.uk+1
7. High-concentration capsaicin patch (clinic-applied)
Capsaicin 8% patch is approved in some regions for peripheral neuropathic pain. It uses a purified chili pepper compound to strongly activate pain fibers, which then become less sensitive over time. The purpose is to provide long-lasting pain relief after a single supervised application on the feet. The mechanism involves depletion of substance P and desensitisation of TRPV1 pain receptors. It can cause intense burning during application, so it is applied by trained professionals.nhs.uk+1
8. Simple pain relievers (paracetamol/acetaminophen)
Mild musculoskeletal aches from overused muscles and joints may respond to paracetamol. It is not very effective for pure nerve pain, but it can help layered pain from joints and soft tissues. The purpose is short-term relief when stronger drugs are not needed. It works mainly in the brain to reduce pain and fever, but overdose can damage the liver, so doses must stay within daily limits and be guided by a doctor, especially in children or teens.nhs.uk
9. Non-steroidal anti-inflammatory drugs (NSAIDs)
Medicines like ibuprofen or naproxen may help joint pain, tendon strain, and inflammation around deformed feet. They work by blocking COX enzymes that make prostaglandins, chemicals that cause pain and swelling. In CMT2P, they do not repair nerves but can make walking more comfortable. Side effects include stomach irritation, kidney strain, and, with long use, heart risk, so doctors use the lowest effective dose for the shortest time.nhs.uk+1
10. Muscle relaxants for cramps (for example, baclofen)
Some patients have painful muscle cramps or spasms. Medicines like baclofen act on GABA receptors in the spinal cord to reduce muscle over-activity. The purpose is to ease cramps, improve sleep, and make physiotherapy easier. Side effects can include drowsiness and weakness, so doses must be slowly adjusted.PMC+1
11. Short-term opioids (for severe acute pain, very cautiously)
In rare cases of severe pain not controlled by other medicines, a specialist may use short-term opioid medicines. Their purpose is to rescue the patient from unmanageable pain, but they do not treat the underlying nerve damage. Opioids act on opioid receptors in the brain and spinal cord to blunt pain signals, but they carry risks of constipation, drowsiness, breathing problems, and dependence, so they are used with strict medical supervision and ideally avoided long term.nhs.uk+1
12. Sleep medicines (for severe insomnia)
If nerve pain and cramps cause serious sleep problems, doctors sometimes use short courses of sleep aids or low-dose sedating antidepressants. Better sleep can reduce perception of pain and fatigue. The mechanism depends on the drug (for example, enhancing GABA or melatonin pathways). These medicines must be used carefully in teens because of risks such as dependence, next-day drowsiness, or mood changes.NCBI+1
13. Anti-anxiety and antidepressant medicines (SSRIs/SNRIs)
Living with CMT2P may lead to anxiety or depression, which can amplify pain and fatigue. SSRIs and SNRIs help rebalance serotonin and norepinephrine, which can improve mood and sometimes reduce pain. The purpose is to treat mental health conditions that often travel with chronic disease. These medicines work in the brain’s neurotransmitter systems and need regular follow-up with a doctor to monitor benefits and side effects.NCBI+1
14. Vitamin B12 replacement (if deficient)
If tests show low vitamin B12, doctors may prescribe tablets or injections. B12 is crucial for building myelin and maintaining healthy nerves, and deficiency can cause or worsen neuropathy.Cleveland Clinic+2PubMed+2 In a CMT2P patient with B12 deficiency, correcting the deficiency may improve nerve function on top of the inherited disease. The purpose is to treat a reversible problem, not the genetic CMT itself.
15. Vitamin D replacement (if low)
Vitamin D helps with bone and muscle health. Low levels can increase muscle weakness and fracture risk. If a CMT2P patient has low vitamin D on blood tests, supplements may be recommended. The purpose is to improve bone strength and muscle function so walking is safer. Vitamin D works by helping the body absorb calcium and supporting muscle fibers.nhs.uk
16. Treatment of diabetes or thyroid disease (when present)
If someone with CMT2P also has diabetes or thyroid disorder, treating these conditions is extremely important, because both can worsen neuropathy. Good blood sugar control and correct thyroid hormone levels protect remaining nerve fibers. The medicines used (insulin, metformin, levothyroxine, etc.) do not treat CMT2P directly but prevent additional nerve damage.nhs.uk+1
17. Drugs in clinical trials for CMT (for example, PXT3003 for CMT1A)
Some combination drugs like PXT3003 (baclofen, naltrexone, and sorbitol) have been tested for CMT1A and are in late-stage trials; results so far are mixed.Institut Myologie+3ClinicalTrials.gov+3PMC+3 These are not approved standard treatments for CMT2P but give hope that disease-modifying drugs could be developed in the future for different CMT types, including axonal forms.
18. Experimental agents for neuropathic pain (for example, topical CBD, PEA)
Clinical trials are exploring palmitoylethanolamide (PEA), topical cannabidiol, and other agents for chemotherapy-induced neuropathy.Mayo Clinic+1 These are not standard for CMT2P, but research is increasing overall understanding of neuropathic pain and may lead to new options that could one day be adapted for hereditary neuropathies.
19. Medications for orthostatic symptoms (if autonomic involvement)
If someone with CMT2P has dizziness on standing or other autonomic symptoms, medicines like fludrocortisone or midodrine may be considered. They work by increasing blood pressure or vascular tone. The purpose is to reduce fainting and fatigue. These drugs affect the heart and circulation, so specialist monitoring is essential.nhs.uk+1
20. Medications for associated conditions (for example, scoliosis pain, tremor)
Some CMT patients have tremor, scoliosis-related back pain, or other complications. Beta-blockers, anti-spasticity drugs, or other agents may be used individually. The purpose is to treat each additional problem so that overall function is better. These medicines act on specific body systems (such as muscles or heart) and must be tailored to the patient.PMC+1
Dietary molecular supplements
Evidence for supplements in CMT2P specifically is very limited. Most data come from diabetic or other peripheral neuropathies, and results are mixed. Supplements should not replace medical care and may interact with medicines.
1. Alpha-lipoic acid (ALA)
Alpha-lipoic acid is an antioxidant that has been studied in diabetic neuropathy. Randomized trials suggest that oral or intravenous ALA can modestly improve nerve pain and nerve conduction in some patients, likely by reducing oxidative stress and improving blood flow in small vessels supplying nerves.Cureus+3PubMed+3MDPI+3 Typical studied oral doses for neuropathy are around 600 mg per day, but dosing and duration must be decided by a doctor because side effects like stomach upset and blood sugar changes can occur.
2. Acetyl-L-carnitine (ALC)
Acetyl-L-carnitine has been studied for peripheral neuropathic pain and appears to have a modest effect on pain and nerve regeneration in some trials.Cochrane Library+3PMC+3PLOS+3 It is thought to support energy production in nerve cells and improve mitochondrial function. Doses in studies often range from 1000–3000 mg per day divided, but exact dosing must be supervised. In CMT2P, it may hypothetically support axonal health, but this has not been proven.
3. Omega-3 fatty acids (fish oil)
Omega-3 polyunsaturated fatty acids are important for nerve cell membranes. Animal studies and small human studies suggest they may help nerve regeneration and reduce neuropathic pain, though large high-quality trials in peripheral neuropathy show mixed results.Cochrane Library+3PMC+3PubMed+3 Supplements usually contain EPA and DHA, and doses vary, often around 1–3 g per day of combined omega-3s, but should be discussed with a doctor because of bleeding risk and interactions.
4. Vitamin B12 (cobalamin)
Vitamin B12 is critical for normal myelin and DNA synthesis in nerve cells. Deficiency clearly causes neuropathy, and treatment with B12 can reverse or improve symptoms in those cases.Cleveland Clinic+2PubMed+2 In CMT2P, B12 supplementation is only recommended if levels are low or borderline; high-dose B12 is not proven to fix the genetic neuropathy but makes sure there is no extra avoidable damage. Dosing might involve intramuscular injections or high-dose oral tablets as guided by blood tests.
5. B-complex vitamins (B1, B6, B9)
Other B vitamins are also important for nerve health and energy metabolism. Some combination products with B1, B6, B12 and ALA have been tested in diabetic neuropathy with some improvement in symptoms.MedRxiv+1 The purpose is to correct mild deficiencies and support metabolic pathways in nerves. Doses vary widely and must avoid excessive B6, which in high doses can itself cause neuropathy.
6. Vitamin D
Vitamin D supports bone strength and muscle function. In people with neuropathy and balance problems, fractures from falls are a big concern, so good vitamin D levels are important. Some studies suggest low vitamin D is linked to worse neuropathic pain. Supplement doses are based on blood levels and may range from 600–2000 IU per day or more under supervision.nhs.uk+1
7. Magnesium
Magnesium helps with muscle function and nerve signaling. Deficiency may worsen cramps and fatigue. Dietary sources include nuts, seeds, and whole grains; supplements may be used if blood levels are low. The purpose in CMT2P is mainly to support muscle relaxation and general health; there is no strong evidence that magnesium alone treats the neuropathy. Too much can cause diarrhea and, in kidney disease, dangerous levels, so tests and medical advice are needed.Verywell Health+1
8. Coenzyme Q10 (CoQ10)
CoQ10 is involved in mitochondrial energy production and has been studied in some neuromuscular disorders. Evidence in peripheral neuropathy is limited, but in theory it may support energy-hungry nerve cells. Doses in studies often range from 100–300 mg per day. Side effects are usually mild but can include stomach upset and interactions with blood thinners.nhs.uk+1
9. Curcumin (turmeric extract)
Curcumin has anti-inflammatory and antioxidant effects and has been explored in various chronic pain conditions. It may reduce inflammatory signals that can sensitize nerves, but high-quality data in neuropathy is still limited. The purpose in CMT2P would be supportive, not disease-modifying. Curcumin supplements vary widely in dose and absorption, so medical and pharmacy advice are important.nhs.uk+1
10. Resveratrol and other polyphenols
Polyphenols like resveratrol are plant compounds with antioxidant and anti-inflammatory actions. Animal studies suggest potential benefits in nerve injury, but human data in neuropathy are scarce. They might support vascular and nerve health indirectly. As with other supplements, they should be seen as optional and only used as part of a plan supervised by a doctor, especially if combined with multiple other products.nhs.uk+1
Immunity-boosting, regenerative and stem-cell–related approaches
Currently there are no approved regenerative or stem cell drugs specifically for CMT2P. What follows are research directions and general concepts, not standard treatments.
1. Gene therapy targeting CMT genes
Researchers are developing gene therapies that replace, silence, or edit faulty genes in CMT. For axonal types like CMT2, strategies may aim to restore or correct genes such as LRSAM1.ScienceDirect+3Institut Myologie+3ScienceDirect+3 These treatments would work by delivering a normal copy of the gene or editing the existing gene using viral vectors or other systems. Trials in some CMT types are still preclinical or early-phase. None are routine clinical care yet.
2. Plasmid-based gene medicines for nerve support
Recent early trials are testing plasmid-based “gene medicines” that deliver protective genes to nerves and muscles without using viruses. In CMT research, one plasmid therapy has shown promising early results in improving nerve and muscle function in small trials.Charcot-Marie-Tooth Disease+2Charcot-Marie-Tooth Association+2 The idea is to boost production of helpful proteins that may protect axons or support regeneration. These approaches remain in clinical studies and are not available outside research settings.
3. Mesenchymal stem cell (MSC) therapy for neuropathy
Mesenchymal stem cells from bone marrow, fat, or umbilical cord are being studied in diabetic and other peripheral neuropathies. Meta-analyses suggest they may improve nerve blood flow and conduction in animals and early human work, possibly by releasing growth factors and anti-inflammatory molecules.MDPI+4ClinicalTrials.gov+4ScienceDirect+4 For CMT, MSC approaches are still experimental and must only be tried within proper clinical trials, not commercial “stem cell clinics” that lack strong evidence.
4. Muse cells and other advanced cell therapies for neuropathic pain
Preclinical work on special regenerative cells such as Muse cells shows they can reduce neuropathic pain in animal models by reducing inflammation in the spinal cord and releasing protective cytokines like TGF-β and IL-10.arXiv+1 Although not specific to CMT2P, these studies suggest that in future, cell-based injections might help control chronic nerve pain while also supporting nerve repair. This is currently research-only.
5. Immune-modulating biologic approaches
Some neuropathies are autoimmune, and treatments like IVIG or monoclonal antibodies are used there. CMT2P is not an autoimmune disease, but understanding how inflammation interacts with inherited neuropathies might lead to therapies that modulate immune signals around the nerve and reduce secondary damage. For now, such biologics are not routine for CMT2P, and their use would be restricted to trials or special circumstances.ScienceDirect+1
6. Induced pluripotent stem cells (iPSCs) from patients for drug screening
Researchers can take skin or blood cells from people with hereditary neuropathies, turn them into stem cells, and then into nerve cells in the lab. These iPSC-derived neurons are used to model CMT and screen candidate drugs safely.Mayo Clinic+2PubMed+2 This does not yet treat the patient directly, but it is a powerful regenerative medicine tool that may discover future drugs or gene therapies tailored to specific mutations like LRSAM1.
Surgical treatments
1. Foot soft-tissue surgery (tendon lengthening and release)
In CMT2P, tight calf muscles and Achilles tendons can cause toe-walking and prevent the heel from touching the ground. Surgeons may lengthen the Achilles tendon or release tight soft tissues to allow a flatter foot position. The purpose is to improve walking, reduce pain, and make bracing easier. Surgery works by physically changing the length and balance of tendons so the ankle can move through a more normal range.nhs.uk+1
2. Tendon transfer surgery
Some tendons from stronger muscles can be rerouted to help weaker ones, such as transferring a tendon to lift the foot better and reduce foot drop. The purpose is to rebalance muscle forces around the ankle and foot. This works by giving a new function to a still-strong muscle so that the foot can clear the ground and walking becomes safer and less tiring.Physiopedia+1
3. Osteotomy (bone-reshaping) for cavus foot
High arches (pes cavus) can cause severe pressure on the ball and heel of the foot and lead to calluses and pain. In more advanced cases, surgeons may cut and realign bones in the foot to flatten the arch and improve weight distribution. The purpose is long-term pain relief and better stability. This works by changing the structure of the foot so that braces and shoes fit better and pressure is spread more evenly.nhs.uk+1
4. Fusion surgery for unstable joints
If certain joints (for example, in the midfoot) are very unstable and painful, fusion surgery may be offered. In this procedure, the joint surfaces are joined together so the joint no longer moves. The purpose is to remove painful abnormal motion and provide a solid base for standing and walking. The trade-off is loss of some flexibility, so this is usually reserved for severe deformities.nhs.uk+1
5. Spine surgery for severe scoliosis
If CMT2P is associated with significant scoliosis affecting posture, breathing, or pain, spinal fusion or other corrective surgery may be considered, especially in adolescence. The purpose is to straighten and stabilize the spine, protect lung function, and prevent progression. The surgery works by placing rods and screws to hold the spine in a corrected position until the bones fuse. This is major surgery and requires careful team decision-making.PMC+1
Prevention and lifestyle risk reduction
Protect your feet every day – Check feet for blisters, cuts, or redness, because reduced sensation means small injuries can go unnoticed and become serious.nhs.uk+1
Choose safe footwear – Wear well-fitting shoes with closed toes, cushioned soles, and no high heels. Avoid walking barefoot or in flip-flops, especially outdoors.nhs.uk+1
Keep a healthy body weight – Extra weight increases load on weak feet and ankles and may worsen pain and fatigue; balanced diet and activity help.nhs.uk+1
Avoid smoking and heavy alcohol use – Both can damage blood vessels and nerves, adding extra damage on top of CMT2P.nhs.uk+1
Manage other health conditions early – Control diabetes, thyroid problems, and vitamin deficiencies quickly so they do not worsen neuropathy.nhs.uk+1
Use braces and orthotics as prescribed – Wearing AFOs or splints regularly can prevent falls and deformities; skipping them may allow problems to progress.Mayo Clinic+2Charcot-Marie-Tooth Association+2
Stay active but avoid over-exertion – Regular light to moderate exercise keeps muscles and heart healthy, but high-impact or very intense sports can increase injury risk.PMC+1
Make home and school safer – Good lighting, railings, non-slip bathroom floors, and tidy walkways all reduce fall risk.Mayo Clinic+1
Keep vaccination up to date – General vaccines, especially those preventing serious infections, help avoid illnesses that could temporarily worsen weakness or cause hospital stays.nhs.uk+1
Stay linked to specialist care and support groups – Regular reviews and up-to-date information help you adapt treatment early and learn about new research opportunities.PMC+2CMT Research Foundation+2
When to see doctors
You should see a neurologist, pediatric neurologist, or neuromuscular specialist regularly for CMT2P, even if symptoms are stable. Go back to the doctor sooner if you notice:
New or rapidly worsening weakness in feet, hands, or legs.
Sudden big increase in falls or trouble walking.
New severe pain that does not improve with your usual plan.
Changes in breathing (shortness of breath, waking gasping) or sleep problems.
New swallowing problems or choking.
Signs of infection in the feet such as redness, warmth, swelling, or discharge.ScienceDirect+3Mayo Clinic+3nhs.uk+3
Emergency care is needed if there is sudden loss of ability to walk, loss of bladder/bowel control, severe shortness of breath, or chest pain. Even though CMT2P usually progresses slowly, other unrelated conditions can appear and must be treated quickly.Mayo Clinic+1
What to eat and what to avoid
Eat: balanced meals with vegetables, fruits, whole grains and lean protein; Avoid: very sugary drinks and snacks. This supports nerve and muscle health and helps prevent diabetes, which can worsen neuropathy.nhs.uk+1
Eat: foods rich in B12 and other B vitamins (fish, eggs, dairy, fortified cereals); Avoid: long-term highly restrictive diets without medical guidance. This lowers risk of deficiency-related nerve damage.Cleveland Clinic+2PubMed+2
Eat: foods with omega-3s (fatty fish like salmon, walnuts, flaxseeds); Avoid: large amounts of deep-fried fast food. Omega-3s may support nerve membranes and cardiovascular health.PMC+2PubMed+2
Eat: nuts, seeds, legumes and whole grains for magnesium; Avoid: too many salty processed snacks. Magnesium helps muscles and nerves and overall metabolic health.Verywell Health+1
Eat: adequate protein (fish, chicken, beans, lentils); Avoid: very low-protein diets. Protein is needed to maintain muscles that support weak joints.nhs.uk+1
Eat: calcium and vitamin-D-rich foods (dairy, fortified plant milks, small fish with bones); Avoid: heavy cola consumption, which can affect bone health. Strong bones lower fracture risk if falls occur.nhs.uk+1
Eat: plenty of water; Avoid: high intake of sugary energy drinks or excessive caffeine. Good hydration supports circulation and prevents fatigue swings.nhs.uk+1
Eat: anti-inflammatory foods (berries, leafy greens, olive oil, spices like turmeric); Avoid: large quantities of processed meats and trans-fat snacks. Anti-inflammatory diets may modestly support chronic pain management.nhs.uk+1
If overweight, eat: slightly smaller portions and more fiber; Avoid: crash diets. Slow, steady weight control is safer for people with chronic disease and helps mobility.nhs.uk+1
Discuss all supplements with your doctor; Avoid: stacking many high-dose supplements without medical advice. This prevents harmful interactions and unnecessary cost.nhs.uk+2Cochrane Library+2
Frequently asked questions
1. Can CMT2P be cured?
No, at present there is no cure for Charcot-Marie-Tooth disease axonal type 2P. Management focuses on symptom relief, maintaining mobility, and preventing complications with therapies, braces, lifestyle changes, and pain medicines. Research into gene therapy and regenerative approaches is active and promising but still experimental.Genetic Rare Diseases Center+2Physiopedia+2
2. Will everyone with CMT2P end up in a wheelchair?
Not necessarily. Many people remain able to walk, especially with early physiotherapy, bracing, and good foot care. Some may need a wheelchair for long distances or later in life. The course is variable, so regular specialist follow-up helps adapt treatment as needed.Genetic Rare Diseases Center+2PMC+2
3. At what age do symptoms usually start?
CMT2P can start in childhood, teenage years, or adulthood. Often the first signs are frequent tripping, difficulty running, or ankle sprains. In some families, symptoms are mild and may not be noticed until later in life. Genetic and environmental factors both influence the age of onset.Genetic Rare Diseases Center+2MalaCards+2
4. Is exercise safe or harmful in CMT2P?
Correctly chosen exercise is helpful and should be encouraged. Low-impact activities such as swimming, cycling, and supervised strengthening exercise help preserve muscle and joint health. Very heavy resistance training, high-impact sports, or activities that cause repeated ankle sprains should be avoided. A physiotherapist can design a safe program.nhs.uk+2PMC+2
5. Why is pain so strong if the nerves are damaged?
Neuropathic pain happens because damaged nerves send abnormal signals to the brain, which can be felt as burning, stabbing, or electric shocks. Even when numbness is present, some fibers still fire in a chaotic way. Medicines like gabapentin, pregabalin, and duloxetine act on these pain pathways to calm them down.FDA Access Data+3NCBI+3Cochrane Library+3
6. Are gabapentin and pregabalin safe for long-term use?
These drugs can be very helpful for many people with neuropathic pain, but like all medicines, they have possible side effects such as dizziness, sleepiness, weight gain, and mood changes. Recent reviews emphasize careful dosing, monitoring, and re-evaluation of need over time.NCBI+2Springer Link+2 Decisions should be personalized by your doctor; never change dose or stop suddenly without medical advice.
7. Do high-dose vitamin C or other supplements cure CMT?
High-dose ascorbic acid (vitamin C) helped in mouse models of some CMT types, but multiple randomized trials in CMT1A humans showed no significant clinical benefit.Pediatric Neurology Briefs+4PubMed+4The Lancet+4 Supplements may support general health but have not cured CMT in people.
8. How important are braces (AFOs) really?
Braces are very important for many people with CMT, because they reduce falls, correct foot drop, and improve walking efficiency. Studies show that orthoses and appropriate shoes can significantly improve mobility and quality of life when chosen and adjusted correctly by specialists.ScienceDirect+3Charcot-Marie-Tooth Association+3nhs.uk+3
9. Can surgery make my feet “normal” again?
Surgery can improve alignment, reduce pain, and help shoes and braces fit better, but it does not cure the underlying nerve problem. Over time, further changes may occur and more adjustments may be needed. The decision for surgery is based on pain, deformity, and difficulty walking, not on appearance alone.nhs.uk+2Physiopedia+2
10. Is CMT2P always inherited from a parent?
CMT2P is usually inherited in an autosomal dominant or recessive pattern, but new (de novo) mutations can happen. Genetic testing and counseling are needed to understand the pattern in a specific family and to discuss testing for relatives if appropriate.ScienceDirect+3Genetic Rare Diseases Center+3MalaCards+3
11. Are gene therapy treatments available for CMT2P now?
No gene therapy is yet approved for CMT2P, but research on gene replacement, gene silencing, and gene editing for several CMT subtypes is moving forward in animal and early human studies.ScienceDirect+3Institut Myologie+3PubMed+3 Clinical trials will be needed before such therapies can become standard treatments.
12. Can diet alone fix my neuropathy?
A healthy diet is very important for overall health, weight control, and preventing extra nerve damage from diabetes or vitamin deficiencies, but it cannot reverse the genetic changes in CMT2P. Diet is a strong helper, not a stand-alone cure.nhs.uk+2Cleveland Clinic+2
13. Should I avoid all sports?
You do not need to avoid all sports. Many people with CMT enjoy swimming, cycling, or walking on safe surfaces. The key is to choose low-impact activities that do not create repeated ankle sprains or heavy joint impact. Team sports that involve jumping, sprinting, or sudden direction changes may be risky and should be discussed with your physiotherapist.PMC+2ScienceDirect+2
14. Is it safe to become pregnant if I have CMT2P?
Many people with CMT have successful pregnancies. However, pregnancy can temporarily increase symptoms such as weakness or pain because of weight gain and hormonal changes. Genetic counseling is important to understand inheritance risks. Obstetricians and neurologists should coordinate care to plan safe delivery and pain control.Genetic Rare Diseases Center+2Cleveland Clinic+2
15. What is the most important thing I can do right now?
The single most important step is to be followed by a neuromuscular team (neurologist, physiotherapist, orthotist, and others), use braces or insoles if prescribed, protect your feet daily, stay active with safe exercises, and treat any extra medical problems like vitamin deficiencies or diabetes early. This combined approach gives your nerves and muscles the best chance to stay as strong and functional as possible over time.nhs.uk+4Mayo Clinic+4nhs.uk+4
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 22, 2025.
